Alloy Therapeutics: Funding, Investors & Team (Sep 2026)
Alloy Therapeutics makes medicine by democratizing access to foundational drug discovery platforms and services. Alloy-Gx, its first platform, is a royalty-free suite of immunocompetent transgenic mice enabling best-in-class in vivo human antibody discovery. Founded in 2017, Alloy Therapeutics is headquartered in Lexington, Massachusetts.
Alloy Therapeutics has raised $157M across 3 funding rounds on record, the most recent a Series E of $40.0M announced in Apr 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Alloy Therapeutics Company Profile and Key Stats
Latest funding round on record: Apr 2026.
Alloy Therapeutics Funding Rounds
Alloy Therapeutics raised $75.0M in a Series C announced in Apr 2021.
1.5 years later, a Series D of $42.0M was announced in Oct 2022.
3.5 years later, a Series E of $40.0M was announced in Apr 2026.
Alloy Therapeutics Founders and Leadership Team
Contact details for the Alloy Therapeutics team: 2 of 3 have an email address on file.
Start 14-day free trial →Alloy Therapeutics Funding Compared to Other Biotechnology Startups
Alloy Therapeutics' latest round of $40.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Alloy Therapeutics in Biotechnology and Lexington
Companies Similar to Alloy Therapeutics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Alloy Therapeutics Funding FAQs
What does Alloy Therapeutics do?
Alloy Therapeutics makes medicine by democratizing access to foundational drug discovery platforms and services. Alloy-Gx, its first platform, is a royalty-free suite of immunocompetent transgenic mice enabling best-in-class in vivo human antibody discovery. Founded in 2017, Alloy Therapeutics is headquartered in Lexington, Massachusetts.
How much funding has Alloy Therapeutics raised?
Alloy Therapeutics has raised $157M across 3 rounds on record. The most recent is a Series E of $40.0M announced in Apr 2026.
When did Alloy Therapeutics last raise funding?
Alloy Therapeutics' most recent funding round on record is a Series E of $40.0M, announced in Apr 2026.
Who founded Alloy Therapeutics?
FundedIQ lists Christian Cobaugh (Founder) at Alloy Therapeutics.
Who is the CEO of Alloy Therapeutics?
Dongxing Zha is listed as CEO at Alloy Therapeutics.
Where is Alloy Therapeutics headquartered?
Alloy Therapeutics is based in Lexington, Massachusetts, United States.
How many employees does Alloy Therapeutics have?
Alloy Therapeutics is in the 101-250 employee band.
How does Alloy Therapeutics' funding compare to other Biotechnology startups?
Alloy Therapeutics' latest round of $40.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Alloy Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Alloy Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.